These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6465906

  • 1. Erythema chronicum migrans of Lyme disease.
    Berger BW.
    Arch Dermatol; 1984 Aug; 120(8):1017-21. PubMed ID: 6465906
    [Abstract] [Full Text] [Related]

  • 2. Lyme disease is a spirochetosis. A review of the disease and evidence for its cause.
    Berger BW, Clemmensen OJ, Ackerman AB.
    Am J Dermatopathol; 1983 Apr; 5(2):111-24. PubMed ID: 6410931
    [Abstract] [Full Text] [Related]

  • 3. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease.
    Asbrink E, Olsson I.
    Acta Derm Venereol; 1985 Apr; 65(1):43-52. PubMed ID: 2578705
    [Abstract] [Full Text] [Related]

  • 4. [Etiology of erythema migrans disease and Lyme disease. Review and results of personal study].
    Neubert U.
    Hautarzt; 1984 Nov; 35(11):563-70. PubMed ID: 6519987
    [Abstract] [Full Text] [Related]

  • 5. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
    Maraspin V, Lotric-Furlan S, Strle F.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):616-9. PubMed ID: 12422612
    [Abstract] [Full Text] [Related]

  • 6. Ixodes ricinus spirochete and European erythema chronicum migrans disease.
    Ackermann R, Kabatzki J, Boisten HP, Steere AC, Grodzicki RL, Hartung S, Runne U.
    Yale J Biol Med; 1984 Jul 31; 57(4):573-80. PubMed ID: 6393609
    [Abstract] [Full Text] [Related]

  • 7. Lyme borreliosis.
    Scarpa C, Trevisan G, Stinco G.
    Dermatol Clin; 1994 Oct 31; 12(4):669-85. PubMed ID: 7805296
    [Abstract] [Full Text] [Related]

  • 8. Lyme disease in northern California.
    Campagna J, Lavoie PE, Birnbaum NS, Furman DP.
    West J Med; 1983 Sep 31; 139(3):319-23. PubMed ID: 6636745
    [Abstract] [Full Text] [Related]

  • 9. [Erythema migrans disease. A contribution to its clinical features and relation to Lyme disease].
    Weber K, Puzik A, Becker T.
    Dtsch Med Wochenschr; 1983 Aug 05; 108(31-32):1182-90. PubMed ID: 6872871
    [Abstract] [Full Text] [Related]

  • 10. Ixodes dammini: induced skin lesions in guinea pigs and rabbits compared to erythema chronicum migrans in patients with lyme arthritis.
    Krinsky WL, Brown SJ, Askenase PW.
    Exp Parasitol; 1982 Jun 05; 53(3):381-95. PubMed ID: 7084401
    [No Abstract] [Full Text] [Related]

  • 11. Microbiological findings in erythema (chronicum) migrans and related disorders.
    Neubert U, Krampitz HE, Engl H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec 05; 263(1-2):237-52. PubMed ID: 3577483
    [Abstract] [Full Text] [Related]

  • 12. Epidemiological survey of human borreliosis diagnosed in Eastern Slovakia.
    Stefancíková A, Pet'ko B, Rozická I, Salyová N, Ohlasová D.
    Ann Agric Environ Med; 2001 Dec 05; 8(2):171-5. PubMed ID: 11748874
    [Abstract] [Full Text] [Related]

  • 13. [The spirochetal etiology of erythema chronicum migrans and Garin-Bujadoux-Bannwarth meningo-polyneuritis].
    Ackermann R.
    Fortschr Med; 1983 Jul 07; 101(25):1167-70. PubMed ID: 6884950
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM.
    Clin Dermatol; 2006 Jul 07; 24(6):509-20. PubMed ID: 17113969
    [Abstract] [Full Text] [Related]

  • 15. Epidemiologic features of Lyme disease in New York.
    Hanrahan JP, Benach JL, Coleman JL, Bosler EM, Grabau JC, Morse DL.
    Yale J Biol Med; 1984 Jul 07; 57(4):643-50. PubMed ID: 6334940
    [Abstract] [Full Text] [Related]

  • 16. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
    Logar M, Lotric-Furlan S, Maraspin V, Cimperman J, Jurca T, Ruzić-Sabljić E, Strle F.
    Wien Klin Wochenschr; 1999 Dec 10; 111(22-23):945-50. PubMed ID: 10666806
    [Abstract] [Full Text] [Related]

  • 17. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B, Glatz M, Kerl H, Müllegger RR.
    Clin Exp Dermatol; 2006 Jul 10; 31(4):509-14. PubMed ID: 16716151
    [Abstract] [Full Text] [Related]

  • 18. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR, Zoechling N, Soyer HP, Hoedl S, Wienecke R, Volkenandt M, Kerl H.
    Arch Dermatol; 1995 Jun 10; 131(6):678-82. PubMed ID: 7778919
    [Abstract] [Full Text] [Related]

  • 19. [Clinical and morphological characteristics of migrating erythema in patients with Ixodes tick-borne Lyme disease].
    Ziuzia IuR, Efimova NS, Vorob'eva NN, Klitsunova NV, Gosteva VV.
    Med Parazitol (Mosk); 1999 Jun 10; (4):36-41. PubMed ID: 11221003
    [Abstract] [Full Text] [Related]

  • 20. Children with multiple erythema migrans: are there any pre-treatment symptoms and/or signs suggestive for central nervous system involvement?
    Arnez M, Pleterski-Rigler D, Luznik-Bufon T, Ruzić-Sabljić E, Strle F.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):524-9. PubMed ID: 12422594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.